List of works - Ngo Thi Kim Yen

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

scientific article

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

scientific article

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

scientific article

Applicability and variability of liver stiffness measurements according to probe position

scientific article published on July 2009

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.

scientific article

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

scientific article

Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference

scientific article published on 5 February 2018

Impact of steatosis and inflammation definitions on the performance of NASH tests.

scientific article published in April 2018

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

scientific article

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

scientific article

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study

scientific article

Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.

scientific article

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

scientific article published on 24 May 2013

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

scientific article

Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population

scientific article published on 18 May 2012

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".

scientific article published on 9 June 2014

List of works by Ngo Thi Kim Yen

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

Applicability and variability of liver stiffness measurements according to probe position

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference

Impact of steatosis and inflammation definitions on the performance of NASH tests.

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study

Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".